BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
311 – 320 of 3089
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Vi måste ta ställning till den nya gentekniken
2019) In Svenska Dagbladet, Stockholm(
- Contribution to specialist publication or newspaper › Newspaper article
-
Mark
Cytotoxicity of New Damsin Derivatives in Breast Cancer Cells
(
- Contribution to journal › Article
-
Mark
Selective Cytotoxicity of Damsin Derivatives in Breast Cancer Cells
(
- Contribution to journal › Article
-
Mark
Structural comparison of protiated, H/D-exchanged and deuterated human carbonic anhydrase IX
(
- Contribution to journal › Article
-
Mark
Crizotinib and PARP inhibitors act synergistically by triggering apoptosis in high-grade serous ovarian cancer
(
- Contribution to journal › Article
-
Mark
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
(
- Contribution to journal › Article
-
Mark
RTNduals an R/Bioconductor package for analysis of co-regulation and inference of dual regulons
(
- Contribution to journal › Letter
-
Mark
MPRAscore : robust and non-parametric analysis of massively parallel reporter assays
(
- Contribution to journal › Article
-
Mark
Depletion of the transcriptional coactivators CREB-binding protein or EP300 downregulates CD20 in diffuse large B-cell lymphoma cells and impairs the cytotoxic effects of anti-CD20 antibodies
(
- Contribution to journal › Article
-
Mark
Management and outcome of muscle-invasive bladder cancer with clinical lymph node metastases. A nationwide population-based study in the bladder cancer data base Sweden (BladderBaSe)
2019) In Scandinavian Journal of Urology(
- Contribution to journal › Article